PortViewPortView
Modular Medical logo

Modular Medical (MODD) Stock Analysis

NASDAQHealthcareMedical - Devices

$3.75+5.49%
1-year price historyRange $1.87 – $22.83
52-week range$3.75
$1.72$30.00

What Modular Medical does

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

Key metrics

Market cap
$7.91M
P/E (TTM)
-0.76
EPS (TTM)
$-4.93
Beta
0.07
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$3.26
200-day avg
$7.38
52-week high
$30.00
52-week low
$1.72
CEO
James E. Besser

ETFs linked to MODD

Broad-market and Healthcare sector ETFs an investor holding Modular Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MODD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MODD in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Modular Medical?
Modular Medical trades under the ticker MODD on NASDAQ.
Which exchange is MODD listed on?
MODD is listed on NASDAQ.
What sector does Modular Medical operate in?
Modular Medical is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze MODD in a portfolio?
PortView shows MODD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.